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Abstract 
 
Endometriosis is a chronic incurable disorder that affects 1 in 10 women of reproductive age: 
associated symptoms include chronic pain and infertility. The aetiology of endometriosis 20 
remains poorly understood but patients, clinicians and researchers are all in agreement that 
new non-surgical therapies are urgently needed to reduce the severity of symptoms. 
Preclinical testing of drugs requires the development and validation of models that 
recapitulate the key features of the disorder. In this review we describe the best-validated 
animal models (primate, rodent, xenograft) and their contributions to our understanding of the 25 
factors underpinning the development of symptoms. We consider the evidence that these 
models have provided the platform for identification of new therapeutic interventions and 
reflect on future directions for research and drug validation.  
 
KEY WORDS: endometriosis, pain, infertility, neuroangiogenesis, oestradiol, inflammation, 30 
macrophage. 
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General Practice Points  
• Endometriosis is a chronic, incurable hormone-dependent disorder characterized by 35 
the presence of ‘lesions’ which resemble fragments of endometrial tissue at extra-
uterine sites 
• Symptoms include chronic pain and infertility: not all women with lesions have 
symptoms/all symptoms. 
• Endometriosis only develops spontaneously in women and menstruating primates. 40 
• Endometriosis is considered to be an oestrogen-dependent inflammatory disorder. 
• Endometriosis can be induced experimentally in primates and rodents leading to 
formation of lesions that resemble those found in women. 
• Induction of ‘lesions’ allows investigation of specific processes/targets, but as yet, no 
model completely recapitulates all aspects of the human disorder. 45 
• In animal models inhibition of oestrogens or inflammatory signals can reduce lesion 
growth and pain symptoms. 
 
 
  50 
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1. Introduction. 
 
Endometriosis is an incurable disorder that is estimated to have an impact on the health and 
wellbeing of ~1 in 10 women of reproductive age (1). The defining characteristic of the 
disorder is the presence of tissue fragments (lesions) that contain stromal, epithelial and 55 
inflammatory cells mimicking the appearance of uterine (eutopic) endometrium. The time to 
diagnosis is estimated to be 7 years from the time the symptoms first appear (2) and definitive 
diagnosis is only achieved by a surgical laparoscopy. Depending upon the number, location 
and appearance of the lesions, three broad subtypes have been postulated; peritoneal, ovarian 
and deep infiltrating. These phenotypes are further classified, according to the criteria set by 60 
the American Society for Reproductive Medicine into stage 1 (minimal), stage 2 (mild), stage 
3 (moderate) or stage 4 (severe) (3).  
  
One of the most debilitating symptoms of endometriosis is chronic pain that may be constant 
or associated with fluctuations in the menstrual cycle. In their 2007 study, Vercellini et al (4) 65 
analysed the association between patient clinical characteristics, lesion type, disease stage and 
severity of pain symptoms in a cohort of 1054 women having surgery for endometriosis and 
concluded that ‘the association between endometriosis stage and severity of pelvic symptoms 
was marginal and inconsistent’, a finding that has been replicated in other reports on smaller 
groups of women with endometriosis (5). Landmark studies by Berkley and Stratton have 70 
redefined the relationship between lesions and pain symptoms by considering the evidence 
that endometriotic lesions can develop their own nerve supply, thereby creating a direct and 
two-way interaction between lesions and the CNS [reviewed in (6)]. Asante and Taylor 
coined the term ‘neuroangiogenesis’ to describe the extensive cross-talk between nerves and 
blood vessels by which lesions develop a unique local neuronal and vascular supply (7). It is 75 
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also notable that recent studies have reported that in addition to physical pain symptoms, 
psychological factors such as stress, anxiety and depressive symptoms all have a negative 
impact on the health-related quality of life of women living with endometriosis (8). These 
findings have stimulated a great focus on the mechanisms that might alter pain perception in 
women with endometriosis and prompted an increase in the efforts to develop relevant 80 
preclinical models to investigate mechanisms and test potential therapies (6) (see section 5). 
  
The incidence of endometriosis may be as high as 50% in women presenting at infertility 
clinics and a recent paper reported that the chance of having a baby even with IVF or ICSI 
was significantly reduced in women with endometriosis compared to women without the 85 
condition (9). 
  
Why women develop symptomatic endometriosis remains something that is the subject of 
intense research interest. Whilst the most widely accepted theory for the formation of lesions 
is that of ‘retrograde menstruation’ that was proposed by Sampson 90 years ago (10), 90 
numerous commentators have concluded that this cannot explain why some but not all women 
develop symptomatic lesions and factors including the peritoneal environment, reduced 
immune surveillance, persistence of stem cells and oestrogenic stimulation, all being 
considered (1,11-13).  Currently there is an increased interest in using genome wide 
association studies to better understand the risks/aetiology of endometriosis. A concerted 95 
international effort is underway using many thousands of samples (14). The hope is that these 
studies may help identify targets to improve diagnosis. 
1.1. Priorities for Research in Endometriosis 
The World Endometriosis Society [WES, http://endometriosis.org/] has brought together 
many of the key stakeholders interested in advancing understanding of endometriosis and its 100 
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treatments. It works closely with WERF (the World Endometriosis Research Foundation, 
http://endometriosis.ca/research/werf/), which was formed in response to the need to 
accelerate research activities related to improving understanding of the aetiology of the 
disease and foster development of new therapies. These groups have brought together 
researchers and clinicians and published a series of papers detailing protocols for collection of 105 
tissues and fluids for research as well as research priorities (15). Of note, many of the research 
priorities include recommendations building on the use of animal models. A recent exercise in 
priority setting that sought the views of patients, their supporters, researchers, as well as those 
involved in their care (clinicians and allied health professionals) has published a ‘Top 10’ of 
research priorities (16). Tools to address these challenges include extensive use of human 110 
tissue resources (recently reviewed in (17)), as well as a range of animal models which are 
reviewed below. 
 
2. Methodology. 
A search was conducted on Medline (Pubmed) using the search terms ‘animal model’ and 115 
‘endometriosis’ on 15/8/17. All abstracts were read to verify the mention of an animal model 
and 747 papers were identified for further interrogation. Notably, there were a number of 
papers published in 2016/7 consistent with the recent identification of research priorities 
related to the aetiology of the disorder as well as the evaluation of drugs and other agents in 
preclinical studies. A further search on 15/10/17 did not result in additional novel models. A 120 
number of reviews previously published on this topic were also read to any historical primary 
publications that were not found during the Pubmed search (17-19). 
 
3. Animal models of endometriosis  
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In a milestone review, Ruth Grummer highlighted the range of species used during the 1980’s 125 
and 1990’s in animal models for endometriosis research, identifying a number of small 
laboratory animals including rats, mice, rabbits and hamsters (18): readers are referred to that 
paper for a historical perspective. For the purposes of this review we have focused on models 
that have been shown to recapitulate key features of the human disorder highlighting recent 
adaptations which appear to offer promise for understanding the aetiology of the disorder or 130 
as a platform for preclinical testing. 
 3.1 Primates 
Menstruating primates can develop spontaneous disease although detection rates are generally 
reported as being low, in part because females are often only detected when the severity of 
their symptoms results in obvious changes in behaviour. Spontaneous disease with lesions 135 
resembling those in women was reported in cynomolgus monkeys in a large breeding facility 
in Japan (20,21). In these animals, symptoms included decreased food consumption (21); in a 
group of 27 retired breeders the majority had cystic lesions and co-incident adenomyosis was 
also detected (20). Dehoux et al  studied 41 baboons at a Kenyan primate facility using 
laparoscopy to prospectively monitor them for 11 months (22). In that time only two animals 140 
developed spontaneous disease (4.8%). They subsequently used endocervical canal to 
encourage flow of shed endometrium into the peritoneal cavity but reported that only 5 out of 
30 females developed lesions after 9 months. In the conclusion to their paper they speculated 
that baboons may have retained some mechanisms that promote peritoneal healing now lost in 
women and this may limit their use in studies on endometriosis.  145 
However, other groups, notably those led by d’Hooghe (23,24) and Fazleabas (25,26) have 
established reproducible protocols to induce lesions in the peritoneum of baboons based on 
autologous inoculation of menstrual tissue (summarized in Figure 1) (27). In another study, 
deep nodules have been induced in the baboon model with results suggesting that cell 
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migration played an important role in the invasion process of deep lesions in this species (28). 150 
Endometriosis has also been artificially induced in Cynomolus monkeys (29) and the non-
menstruating Common Marmoset monkey (30): the latter is a small primate and may be an 
attractive option for testing compounds in vivo. It has been reported that attempts to induce 
lesions in rhesus macaques were unsuccessful, however, only three rhesus macaques were 
used in that study due to ethical considerations and the rhesus macaques were not cycling so 155 
proliferative stage endometrium was used for lesion induction rather than menstrual tissue 
(31).  
3.2 Rats 
In 1985 Vernon and Wilson explored different ways of inducing ‘endometriosis’ lesions in 
intact rats and reported  that autotransplanting small fragments of uterine horns (myometrium 160 
and endometrium) onto the peritoneum resulted in formation of cystic lesions and impaired 
fertility (32). This model has been adopted and adapted by many groups, most notably by 
Berkley, who refined the method to suture the small pieces of uterus (or fat) onto mesenteric 
arteries, abdomen, and ovary (33-35). This protocol has been widely adopted and proved 
valuable in demonstrating innervation of lesions (34) and informed our understanding of the 165 
pathways that may be activated during pain responses (6,36) (see more details in section on 
models of pain).  
Variants on this model include the stitching of autologous tissue onto the peritoneal wall (37) 
and a new model that recapitulates the phenotype of colo-rectal endometriosis (38). In a more 
radical rat model autologous uterine tissue has been grafted onto the gastrocnemius muscle 170 
(39); although this model does not allow for an evaluation of the role of the peritoneum it 
shows promising for testing mediators of sensory nerve activation. 
3.3 Mice 
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Models have been developed in mice to take advantage of access to transgenic lines in which 
genes have been selectively ablated, including those implicated in oestrogen signaling (40-175 
42), inflammatory processes (43) and cells/endometrial tissue expressing fluorescent proteins 
under the control of cell-specific (44) or ubiquitous promoters (45,46). In allogeneic mouse 
models uterine tissue is recovered minced/dissected and either stitched back onto the 
intestinal mesenteric vessels (47), peritoneal wall or injected into the peritoneal cavity (48). 
Pelch et al published a video showing the methodology adapted from the rat, in which tissue 180 
is surgically transplanted onto the intestinal mesentery, which is particularly useful as a 
primer for researchers unfamiliar with the method (49). Authors have also reported that 
recovery of tissue at estrus (highest oestrogen levels) is advantageous: in some cases it has 
been reported that lesions develop cystic structures similar to those reported in the rat (47). 
  185 
More commonly, a syngeneic approach is adopted with the uterine tissue (donor) being 
introduced into a different mouse (recipient): a number of variations of this method have been 
reported (42,44,45,50). Standard methods include removal of uterine horns at diestrus, 
longitudinal opening of the horn to expose the endometrial lining which was cut into small 
fragments e.g. using a biopsy punch and suturing onto the peritoneal wall (41,42). Hirata et al 190 
used GFP-expressing mice as donors and injected minced endometrial fragments into the 
peritoneal cavity of ovariectomised mice supplemented with E2 (51), thus allowing for easier 
identification of lesions. In an elegant series of experiments Ferrero and colleagues used 
decidualised donor endometrial tissue from mice which they recovered and labeled with 
mCherry fluorescent protein ex vivo prior to introducing them into different sites in recipients 195 
(50). Lesions were formed that had epithelial cells forming glands, evidence of inflammatory 
cells, collagen deposits and new blood vessel formation (50). Their results showed that 
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‘lesions’ can be induced in many different locations and provide a framework for non-
invasive monitoring of lesion growth based on imaging. 
 200 
In an attempt to more closely model the mechanisms of ‘retrograde’ menstruation and 
recapitulate the successful induction of lesions in menstruating primates, like the baboon, 
Greaves et al adapted the syngeneic model to use donor tissue from mice in which 
endometrial tissue shedding had been induced by removal of a progesterone pellet following a 
decidual stimulus (52). The menstrual tissue was injected into the peritoneal cavity of 205 
ovariectomised mice who were given an E2 implant resulting in the formation of lesions 
which phenocopied those in women (44) (an overview of the methodology is provided in 
Figure 2). As with other models reporting results from intraperitoneal injection of endometrial 
tissue, the number and location of lesions in each recipient mouse may vary, typically 
between one and three lesions located in the peritoneum or fat. To overcome this limitation 210 
the model was adapted by researchers in Leuven using laparoscopy to position lesions on the 
peritoneum (53). This approach seems to offer advantages over the other peritoneal models 
that may induce surgery-associated trauma, adhesion formation or variations in the 
location/number of lesions, however, it does require access to specialized equipment which 
may not be available to all researchers. 215 
  
An alternative model for induction of lesions using steroid-manipulated, menstrual-like 
endometrium employs K-ras(G12V/+)/Ah-Cre(+/+)/ROSA26R-LacZ(+/+) mice as donors 
and gonad intact wild type mice as recipients (54). Tissue was injected into a subcutaneous 
pocket and allowed to develop without exogenous E2 supplementation. 220 
Immunohistochemistry confirmed that as in human endometriosis, there was invasion and 
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activation of fibroblasts, endothelial cells, and macrophages and collagen deposition in the 
lesions (54).  
3.4 Human cell and tissue xenograft models 
A number of groups have employed a combination of mice (immunosuppressed recipients, 225 
nude, NOD/SCID, Rag2/gammaC) with human cells or tissue samples to model lesions. 
These have the advantage of using a relevant tissue type (human) but use of 
immunocompromised mice limits any modeling of the non-endometrial inflammatory 
contribution to lesion formation/development. Jafarabadi and colleagues demonstrated that 
subcutaneous transplantation of isolated human endometrial tissue or cultured primary human 230 
endometrial mesenchymal (CD90+) cells both result in the formation of endometriotic lesions 
in gamma irradiated mice (55). Xenografts of mixed populations of human immortalized 
endometriosis epithelial and stromal cells can also develop into lesions within the peritoneum 
which were able to reorganise, proliferate, form glands and express regulatory molecules 
including ERalpha, prostaglandin receptors and COX-2 (56). Hull and colleagues have used a 235 
refinement of this model in which human endometrial tissue fragments are xenografted into 
nude mice (57-59). In other studies, whilst human tissue grafts initially retained their own 
blood vessels, over time, they connected to the murine vasculature and became functional 
(60). New xenograft models including use of recipients that have been ‘humanized’ so that 
they contain human immune cells are under development but as yet there are no peer-240 
reviewed publications reporting results. Such refinements may enhance the utility of 
xenografts for preclinical testing of drugs. 
 
4. Contributions of Animal Models to Processes that may contribute to symptoms of 
pain and infertility. 245 
4.1 Immune cells and inflammation  
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The peritoneal fluid of women with endometriosis contains higher concentrations of pro-
inflammatory cytokines and prostaglandins and changes in immune cell complement 
(reviewed in (12)). There is also evidence that proinflammatory molecules, including 
prostaglandins (e.g. PGF2α, PGE2) that are produced by macrophages and other endometrial 250 
cells, act via their cognate receptors (FP, EP1-4) within endometrial lesions. In a xenograft 
model (nude mice, human tissue fragments), treatment with the FP antagonist AL8810 led to 
a decline in the number and size of lesions and downregulation of MMPs and VEGF (61).  In 
other studies authors have used athymic immunocompromised (RAG2/gamma c) mice that 
lack T cells and implanted these with human cell lines derived from an active peritoneal 255 
lesion. They showed that treatment of the mice with specific EP2 and EP4 antagonists 
decreased angiogenesis and innervation of the resulting xenografts (62). This model has 
limitations as  reports using a baboon model suggest the presence of endometriosis in intact 
animals  may have specific impacts on Treg cells (63). Notably this is a T cell subset which 
has been implicated in exacerbating endometriosis in women (64) and which merits further 260 
study.   
 
Allogeneic and syngeneic rodent models overcome the limitations of the xenograft models in 
immune deficient hosts and have been used extensively to investigate the role of immune 
cells and inflammatory mediators in the development of lesions. For example, using uterine 265 
allografts in E2-supplemented mice, Lin et al (65) reported infiltration of neutrophils into 
ectopic tissue on days 1-4 and whilst macrophage numbers did not change, secretion of 
macrophage-derived angiogenic factors increased. A role for alternatively activated 
macrophages in the establishment of lesions has been explored using a mouse model in which 
macrophages were depleted in recipients. Depletion resulted in lesions that failed to organize 270 
and develop whereas adoptive transfer of alternatively activated macrophages dramatically 
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enhanced their growth (66). When Greaves et al (44) used Macgreen mice (mice with GFP 
expressed in CSF1R-positive cells; predominantly monocytes and macrophages), they 
reported that macrophages from both the peritoneal cavity (recipients) and donor 
endometrium can contribute to the resident immune cell population of the lesions. In a 275 
syngeneic mouse model, Azuma et al reported that bi-weekly intraperitoneal injection of the 
pro-inflammatory mediator lipopolysaccharide (LPS) was associated with increased cell 
proliferation, increased immune cells and favoured the development of lesions (67). Guo and 
colleagues have also provided novel evidence that platelets are an important source of TGF-
β1, which can in turn have immunosuppressive effects (68). They used a previously validated 280 
mouse model in which endometrial fragments from syngeneic donors are injected into the 
peritoneal cavity (69) of E2 treated recipients and showed platelet depletion in recipients 
significantly reduced lesion size, cell proliferation, VEGF and TGF-β1 in the resultant 
‘lesions’ (68).  
4.2. Oestrogens and oestrogen receptors  285 
Studies in animal models have complemented and extended evidence from human studies that 
endometriotic lesions contain higher concentrations of oestrogens, increased amounts of 
oestrogen biosynthetic enzymes and multiple oestrogen receptor-positive cells (70). These 
results were extended by analysis of lesions in the Baboon, where it was reported that ERß 
was rapidly up-regulated in newly formed lesions but upregulation of P450 aromatase was not 290 
detectable until 10 months after induction (71), showing the value of a model where lesions 
can be studied from time of induction as a complement to human studies where lesions are 
likely to be long established at the time of removal.  
 
In their mouse model, Greaves et al reported that lesions formed 3 weeks after induction 295 
recapitulated features of the human disease with overexpression of ERß (44). In further 
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studies they reported the macrophages in lesions were ERß-positive (72) and that treatment of 
mice with induced endometriosis with the ERß-selective agonist DPN can alter growth of 
lesion-associated blood vessels and nerves (73). Burns et al reported that compared with WT 
lesions transplanted into WT hosts, WT lesions were proliferative in ERαKO recipient mice 300 
but showed decreased inflammatory responses upon E2 treatment (40). The Katzenellenbogen 
group has used mice with peritoneal lesions induced using endometrial fragments stitched 
onto the peritoneal wall to explore the role of oestrogens/oestrogen receptors in lesion 
formation and associated inflammatory responses (41,42). They also used genetically 
modified mice (both donor and recipient) to explore a potential role for the ER coregulator, 305 
repressor of ER activity (REA) in the pathogenesis of the disorder. Their studies in mice, 
which were complemented by in vitro studies on human stromal cells, suggest this factor 
modulates the oestrogen-dependent interplay between cell types within the lesions (41). 
4.3. Neuroangiogenesis  
The Taylor group recently reviewed evidence that ectopic endometriosis lesions are able to 310 
recruit their own blood supply and advanced the hypothesis that ‘neuroangiogenesis’ (the co-
ordinated growth of new blood vessels and nerves) is important for survival and growth of 
lesions and the associated pain experienced by many patients (7). Evidence for 
neuroangiogenesis in lesions of rats and mice is consistent with the data in women. Notably, 
in rats, mesenteric lesions develop both autonomic and sensory innervation (34) which 315 
becomes functionally active 2-3 weeks post transplantation (74). In the same species, 
endometrial tissues transplanted onto the gastrocnemius muscle also show evidence of 
neuroangiogenesis (39). Greaves and colleagues used their mouse model of endometriosis to 
explore potential regulators of neuroangiogenesis demonstrating a role for oestrogen receptor 
activation in regulation of the axonal guidance molecule Slit3: this factor appeared to promote 320 
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angiogenesis but to decrease neurogenesis providing a link between steroids and 
neuroangiogenesis (73) which merits further investigation.  
 
Practice Points 
• In animal models where lesions or cysts consisting of endometrial tissue 325 
fragments/cells are induced within the peritoneum growth of both new blood vessels 
(angiogenesis) and nerves has been detected. 
• The presence of lesions is associated with changes in the concentrations of 
inflammatory mediators in peritoneal fluid. 
• Lesions contain a diverse population of immune cells including macrophages that may 330 
be derived from either the implanting tissue or the environment in which it becomes 
implanted. 
• Lesions have increased expression of oestrogen receptors which are implicated in 
regulation of proliferation and inflammation.  
 335 
5. Studies using Animal Models to Investigate Mechanisms and Treatments for Pain 
Pain associated with endometriosis has a significant impact on the quality of life of patients 
and development of new and effective therapies is a research priority that requires the 
development of appropriate pre-clinical models of endometriosis. Measurement of ‘pain’ in 
animal models depends upon the evaluation of behavioural responses which may be stimulus-340 
dependent (e.g. von Frey, hotplate, vaginal distension) or spontaneous (e.g. grooming, 
burrowing) with the latter being accepted as a key challenge for researchers (75).  
The rat model of endometriosis, in which cystic lesions are formed on the intestinal mesentery 
(33,34,76), has been used extensively to explore the relationship between the presence of 
lesions, nerve cell growth and pain pathways (reviewed in (6)). The Berkley group has shown 345 
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that rats develop vaginal and abdominal muscle hyperalgesia 4-5 weeks after transplant (74) 
which is exacerbated by oestrogen (76), can be prevented if lesions are removed before they 
become innervated (74) and involves COX enzyme activation (77).  This model has provided 
a platform for testing drugs that might alleviate pain in women with some promising results 
achieved with antagonists directed against cannabinoid (CB1) receptors (78) and anti-350 
inflammatory drugs (77,79).  In a recent study, Herandez et al (80) used the model to test pain 
perception (hyperalgesia – hot plate; allodynia – Von frey) and showed that swimming 
exercise improved some symptoms.  
 
Levine and colleagues used an alternative rat model in which cystic endometriosis-like lesions 355 
developed a local blood and nerve supply following surgical implantation onto the leg 
(gastrocnemius) muscle: in this model they performed measurements of mechanical 
hyperalgesia (39). They also explored the impact of surgical excision (81) and leptin (82) 
using a digital force transducer and single-fibre electrophysiology following stimulation with 
Von Frey fibres. This model allows for a more direct readout of nerve fibre activity in a lesion 360 
than other models but does not model the impact of the peritoneal environment on nerve 
activity. 
 
Mouse models have not been used as extensively as rats but recent advances include a study 
by Greaves et al who showed the presence of peritoneal lesions resulted in upregulation of 365 
prostaglandins, changes in gene expression in dorsal root ganglia and the CNS, and altered 
spontaneous behavior and increased sensitivity to Von Frey testing consistent with abdominal 
hypersensitivity (83). Notably, when drugs targeting PGE2 receptors (EP2, EP4) were 
administered, an orally active selective EP2 antagonist was the most effective in abrogating 
pain responses. These studies complement those in the rat mesenteric cyst model where a 370 
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positive correlation has been demonstrated between peritoneal fluid PGF2a/PGE2 and vaginal 
hyperalgesia (84). 
Practice Points 
• Surrogate measurements of ‘pain’ responses include assessment of both spontaneous 
and evoked responses. 375 
• In rats the presence of endometriosis-like cysts on the mesentery within the abdominal 
cavity is associated with development of both vaginal and abdominal hyperalgesia. 
• Rats have been used to directly measure nerve cell activity by establishing endometrial 
cysts on the leg muscle. 
• Appropriate blinding and randomization in behavioral monitoring is required to 380 
minimize effects of operator bias.  
 
6. Studies using Animal Models to Investigate Mechanisms and Treatments for 
Infertility 
A number of factors have been cited to explain the raised incidence of sub/in-fertility in 385 
women with endometriosis which were summarized by the Practice Committee of the 
American Society for Reproductive Medicine  (ASRM) in 2012 (85). These included changes 
in ovarian and endometrial (eutopic) tissue function, as well as changes in the concentrations 
of pro-inflammatory mediators in peritoneal fluid (12,13). Fertility can only be assessed in 
females where both ovaries and lesions are present and as many models favour 390 
supplementation with E2 to promote lesion growth these are limited in number.  
 
Cynomolgus monkeys with auto-transplantation of endometrium or adipose tissue only 
developed infertility when endometrium was used (29). In this case infertility was associated 
with luteinized un-ruptured follicles, luteal phase defects, and pelvic adhesions. The baboon 395 
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model of endometriosis has been used very effectively to conduct longitudinal sampling of 
endometrium and lesions with studies highlighting changes in the eutopic endometrium that 
only occur many months after induction of lesions. In these studies, endometrium was 
collected during the midsecretory phase between 1 and 16 months after introduction of 
autologous endometrium into the peritoneum and compared with endometrial tissue from 400 
controls, a clear time-dependent change in the patterns of gene expression was recorded (see 
Figure 3) (86). One notable change was in the expression of HOXA10 (87), a progesterone-
regulated gene implicated in fertility that appeared to be differentially methylated in 
endometriosis females.  
 405 
In a recent paper, Bilotas et al (88) induced lesions by syngeneic transplantation onto the 
bowel mesentery of mice and recorded mating and fertility parameters 4 weeks later. They 
reported a decrease in fertility rate and increased IL-2 in the peritoneal fluid with reduced 
lesion size in pregnant females, consistent with pregnancy-associated hormonal changes. 
Studies in rats with induced endometriosis have also revealed that rats with lesions had an 410 
adverse ovarian phenotype including reduced numbers of follicles and luteinized un-ruptured 
follicles (89). In follow-up studies the same group reported that the offspring of rats with 
induced endometriosis exhibited altered gene expression in their own embryos thus providing 
a possible mechanism for the reported increase in incidence in families with endometriosis 
(90). Some interesting data have also been reported in a rabbit model of autologous uterine 415 
transplantation which showed reduced fertility also most likely due to ovarian defects which 
they speculated might have been due to increased PGF concentrations in the peritoneal fluid, 
providing an interesting parallel with more recent rodent studies (91). Women with 
endometriosis are reported to have oocytes that are more likely to fail in vitro maturation and 
to show altered morphology during IVF than women with other causes of infertility (92) and 420 
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in this regard it appears insights from animal models may be further advanced than those in 
women. 
Practice Points 
• Primates with induced endometriosis exhibit time-dependent changes in gene 
expression in their eutopic endometriuim 425 
• In rodent models induction of endometriosis results in changes in the constituents of 
the peritoneal fluid. 
• Infertility in rodents with induced endometriosis has been associated with an adverse 
ovarian phenotype 
 430 
7. Future Directions and Priorities 
A number of models of endometriosis have been developed and their application has 
informed our understanding of genetic factors, regulatory molecules and mechanisms that 
underpin symptoms, including pain and infertility. There are clear advantages to using 
primates, such as the Baboon, in endometriosis research as they have menstrual cycles and 435 
their size allows for repeated sampling of eutopic endometrium and lesions. However, their 
use is very tightly regulated and testing of compounds restricted by the small numbers of 
animals that can be tested. Furthermore, whilst rodent models offer an attractive platform for 
testing of drugs that might treat pain or infertility, each model requires careful validation for 
its particular application – for example the widespread use of ovariectomy and oestrogen 440 
supplementation precludes studies related to infertility and may also compromise those 
related to pain mechanisms. 
 
One topic not yet addressed by existing animal models is the impact of other conditions on 
women with endometriosis. A key example is adenomyosis (invasion of endometrial tissue 445 
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into the muscular wall of the uterus) with reports ranging from 20 to as high as 90% 
prevalence in women. A mouse model of adenomyosis based on treatment of neonatal 
females with oestrogens has been described (93) but apart from tests with GnRH antagonists 
there is limited overlap with studies in endometriosis models. 
 450 
In many cases it is a combination of approaches using one or more animal models that may 
best inform the development of a new therapy or the repurposing of an existing drug. A recent 
example was published by Taylor and colleagues (94). They used the Baboon model of 
endometriosis to extend and validate studies in cells and mice to show that treatment with a 
statin (Simvastatin) decreased the growth of endometrial lesions, modulated the expression of 455 
oestrogen receptors and reduced inflammation. Although this may suggest promise as a drug 
therapy, others have raised concerns about the impact such a treatment may have on fertility 
(95), which perfectly illustrates the challenges faced in moving from results in model systems 
to clinical trials. Furthermore, translation of pre-clinical models will likely require a stratified 
approach as the human disease has a heterogeneous presentation and peritoneal, ovarian and 460 
deep infiltrating endometriosis may represent distinct disease aetiologies. Notably, the 
majority of current animal models recapitulate peritoneal disease and thus translation of 
therapies that show promise will require carefully designed clinical trials with targeted patient 
cohorts to ensure best chance of showing efficacy in humans. More work is needed to 
improve modelling of ovarian and deep infiltrating endometriosis in animal systems to 465 
expand the range of pre-clinical targets and enhance the likelihood of developing new 
successful therapies. 
 
Research Agenda 
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• Endometriosis is a complex disorder and no single animal model can fully recapitulate 470 
the human disorder. 
• Primates can develop natural or induced endometriosis but they are expensive to 
house, cannot be used for large group studies, require large amounts of drugs and it is 
not ethical to use them for routine screening. 
• A widely used rat model develops peripheral and vaginal hyperplasia but lesions are 475 
induced using surgery with a cystic phenotype 
• Xenograft models are limited by the current need to use immune-incompetent 
recipients. 
• Studies on pain mechanisms are increasingly being reported but those focused on 
altered fertility are limited in number. 480 
• New models are needed to model co-morbitities 
• Development of new models is required to compare the impact(s) of peripheral, 
ovarian and deep disease on pain and/or infertility. 
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Figure Legends.  485 
Figure 1. Baboon model of endometriosis. 
Endometriosis can be experimentally induced in adult female olive baboons (Papio anubis) 
by i.p. inoculation of autologous menstrual endometrium on Day 2 of menses for two 
consecutive menstrual cycles. Under laparoscopic guidance, 1 g of menstrual tissue and fluid 
is deposited at four sites: the pouch of Douglas, the uterine fundus, the cul de sac and the 490 
ovaries. Diagnostic laparoscopies accompanied by endometrectomies to harvest eutopic tissue 
are performed on Days 8–12 post-ovulation at 1, 3, 6, 9 and 12 months following the second 
inoculation. Image adapted from a paper published by the Fazleabas group in 2012 (27). 
 
Figure 2. Mouse model of Endometriosis. 495 
Diagram adapted from Greaves et al (44). In this model the ‘donor’ endometrial tissue was 
from a mouse that had been hormonally manipulated so that the endometrial tissue was 
subject to increased tissue degredation (e.g. MMP activation) that mimicked processes 
observed in menstrual tissue from women (52). Endometrial tissue was harvested 4 hours 
after removal of a progesterone pellet (active breakdown). Menstrual tissue was injected i.p. 500 
and lesions were recovered 21 days later. The histology of the lesions resembled those in 
women with overexpression of ERß and evidence of neuroangiogenesis (72). 
 
Figure 3. Summary of the changes in gene expression detected in the eutopic 
endometrium of baboons with induced endometriosis. 505 
Endometrial samples recovered in between 1 and 15 months after induction of endometriosis 
were subjected to genomic analysis as described in (86). Results revealed dynamic temporal 
changes that could be grouped into early, transition or late. One of the key genes which 
changed was HOXA10 and its down regulation in late stage samples would be consistent with 
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observations that endometrium in women exhibits progesterone resistance (87). Image 510 
adapted from (25). 
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